When it comes to cancer, waiting for symptoms may soon be old news. Telehealth company Hims & Hers began offering a blood test this week that screens for a wide range of cancers before warning signs ...

Every time Hilary publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...

Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. Quest Flow ...

Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings as the medtech has now sent off data for a potential FDA approval. Galleri works as a simple blood test that ...

A new study from Chalmers University of Technology in Sweden, along with Oslo University Hospital in Norway, may have discovered a way to detect biomarkers of Parkinson’s disease in the blood up to ...

A telehealth company that generated buzz last year with a defiant Super Bowl ad hawking weight-loss drugs is back for this year’s championship with a socially charged pitch around longevity. “Rich ...

A new screening test is in clinical trials in New Orleans that can find hidden cancer in your body. A Northshore man who joined the free study says it changed the course of his life. “I feel like I ...

Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage cancers by measuring the random variation in DNA methylation patterns, ...

The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced. Dubbed IsoPSA, the in vitro diagnostic kit is ...